PMID- 31664343
OWN - NLM
STAT- MEDLINE
DCOM- 20200701
LR  - 20200701
IS  - 1678-4227 (Electronic)
IS  - 0004-282X (Linking)
VI  - 77
IP  - 10
DP  - 2019
TI  - Effect of Leap Motion-based 3D Immersive Virtual Reality Usage on Upper Extremity 
      Function in Ischemic Stroke Patients.
PG  - 681-688
LID - S0004-282X2019001000681 [pii]
LID - 10.1590/0004-282X20190129 [doi]
AB  - Immersive virtual reality (VR) is a technology that provides a more realistic 
      environmental design and object tracking than ordinary VR. The aim of this study 
      was to investigate the effectiveness of immersive VR on upper extremity function 
      in patients with ischemic stroke. Sixty-five patients with ischemic stroke were 
      included in this randomized, controlled, double-blind study. Patients were 
      randomly divided into VR (n = 33) and control (n = 32) groups. The VR group 
      received 60 minutes of the upper extremity immersive VR rehabilitation program 
      and the control group received 45 minutes of conventional therapy and 15 minutes 
      of a sham VR program. Rehabilitation consisted of 18 sessions of therapy, three 
      days per week, for six weeks. The outcome measures were the Action Research Arm 
      Test (ARAT), Functional Independence Measure (FIM), Fugl-Meyer Upper Extremity 
      Scale (FMUE) and Performance Assessment of Self-Care Skills (PASS). In both the 
      VR and control groups all parameters except the PASS improved over time. However 
      independent t-test results showed that all of the FMUE, ARAT, FIM and PASS scores 
      were significantly higher in the VR group compared with the control (p < 0.05). 
      The minimal clinically important difference (MCID) scores of the FMUE and ARAT 
      were higher than the cut-off MCID scores described in the literature in the VR 
      group, whereas the FIM scores were below the cut-off MCID scores. All scores in 
      the control group were below the cut-off scores. Immersive VR rehabilitation 
      appeared to be effective in improving upper extremity function and self-care 
      skills, but it did not improve functional independence.
FAU - Ogun, Muhammed Nur
AU  - Ogun MN
AUID- ORCID: 0000-0001-5524-5767
AD  - Bolu Abant Izzet Baysal Universitesi; Noroloji Anabilim Dali, Bolu, Turkiye.
FAU - Kurul, Ramazan
AU  - Kurul R
AUID- ORCID: 0000-0001-8605-8286
AD  - Bolu Abant Izzet Baysal Universitesi; Saglik Bilimleri Fakultesi, Fizik Tedavi ve 
      Rehabilitasyon Yuksekokulu, Bolu, Turkiye.
FAU - Yasar, Mustafa Fatih
AU  - Yasar MF
AUID- ORCID: 0000-0001-6715-8388
AD  - Bolu Abant Izzet Baysal Universitesi; Fizik Tedavi ve Rehabilitasyon Anabilim 
      Dali, Bolu, Turkiye.
FAU - Turkoglu, Sule Aydin
AU  - Turkoglu SA
AUID- ORCID: 0000-0001-8616-832X
AD  - Bolu Abant Izzet Baysal Universitesi; Noroloji Anabilim Dali, Bolu, Turkiye.
FAU - Avci, Sebnem
AU  - Avci S
AUID- ORCID: 0000-0003-3712-0551
AD  - Bolu Abant Izzet Baysal Universitesi; Saglik Bilimleri Fakultesi, Fizik Tedavi ve 
      Rehabilitasyon Yuksekokulu, Bolu, Turkiye.
FAU - Yildiz, Nebil
AU  - Yildiz N
AUID- ORCID: 0000-0002-1845-0902
AD  - Bolu Abant Izzet Baysal Universitesi; Noroloji Anabilim Dali, Bolu, Turkiye.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20191024
PL  - Germany
TA  - Arq Neuropsiquiatr
JT  - Arquivos de neuro-psiquiatria
JID - 0125444
SB  - IM
CIN - Arq Neuropsiquiatr. 2019 Oct 24;77(10):679-680. PMID: 31664342
MH  - Activities of Daily Living
MH  - Brain Ischemia/*rehabilitation
MH  - Double-Blind Method
MH  - Female
MH  - Humans
MH  - Male
MH  - Motor Skills/physiology
MH  - Movement/physiology
MH  - Recovery of Function/physiology
MH  - Reference Values
MH  - Socioeconomic Factors
MH  - Statistics, Nonparametric
MH  - Stroke/physiopathology
MH  - Stroke Rehabilitation/*methods
MH  - Time Factors
MH  - Treatment Outcome
MH  - Upper Extremity/*physiopathology
MH  - Virtual Reality Exposure Therapy/*methods
EDAT- 2019/10/31 06:00
MHDA- 2020/07/02 06:00
CRDT- 2019/10/31 06:00
PHST- 2019/04/15 00:00 [received]
PHST- 2019/08/07 00:00 [accepted]
PHST- 2019/10/31 06:00 [entrez]
PHST- 2019/10/31 06:00 [pubmed]
PHST- 2020/07/02 06:00 [medline]
AID - S0004-282X2019001000681 [pii]
AID - 10.1590/0004-282X20190129 [doi]
PST - epublish
SO  - Arq Neuropsiquiatr. 2019 Oct 24;77(10):681-688. doi: 10.1590/0004-282X20190129. 
      eCollection 2019.